Fmoc-EDA.HCl, 99.0%, 100g

7-Methoxy-2-naphthol, 95.0%, 10g

ETHYL 5-ETHYLOXAZOLE-4-CARBOXYLATE, 95.0%, 5g

1-(4-Bromophenyl)-1,2,2-triphenylethylene>98.0%(GC)5g

Methyl 5-fluoro-3-methyl-2-nitrobenzoate, 95.0%, 1g

Methyl 6-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 95.0%, 250mg

Benzo[b]thiophene-2-methanol>98.0%(GC)1g

(S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine, 95.0%, 1g

Tetrabromo-2-sulfobenzoic acid cyclic anhydride, 98.0%, 25g

(S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate, 97.0%, 25g

(3-AMINO-PHENYL)-CARBAMIC ACID BENZYL ESTER, 95.0%, 5g

(S)-2,5-Bis((tert-butoxycarbonyl)amino)pentanoic acid, 95.0%, 100g

Recipiente de cristalización ROTILABO® con pico, 300 ml, 95 mm, 10 Unidad(es)